8-93765648-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PVS1_ModeratePM2PP5
The NM_153704.6(TMEM67):c.651+2T>G variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.0000729 in 1,605,100 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_153704.6 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152246Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251174Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135820
GnomAD4 exome AF: 0.0000764 AC: 111AN: 1452736Hom.: 0 Cov.: 28 AF XY: 0.0000705 AC XY: 51AN XY: 723506
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152364Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74518
ClinVar
Submissions by phenotype
not provided Pathogenic:4
Canonical splice site variant predicted to result in an in-frame loss of the adjacent exon in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 31589614, 16541367, 17160906, 17397051, 19466712, 36090483) -
- -
- -
- -
Meckel syndrome, type 3 Pathogenic:1Uncertain:1
- -
- -
Meckel-Gruber syndrome;C0431399:Familial aplasia of the vermis Pathogenic:1
This sequence change affects a donor splice site in intron 6 of the TMEM67 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in TMEM67 are known to be pathogenic (PMID: 20232449, 23559409). This variant is present in population databases (rs199821258, gnomAD 0.01%). Disruption of this splice site has been observed in individual(s) with Joubert syndrome (PMID: 17160906). ClinVar contains an entry for this variant (Variation ID: 1373). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Joubert syndrome and related disorders Pathogenic:1
Variant summary: TMEM67 c.651+2T>G is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: three predict the variant abolishes the canonical 5' splicing donor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 5.6e-05 in 251174 control chromosomes (gnomAD). This frequency is not higher than the estimated maximum expected for a pathogenic variant in TMEM67 causing Joubert Syndrome and Related Disorders (0.0018), allowing no conclusion about variant significance. c.651+2T>G has been reported in the literature in individuals affected with Joubert Syndrome and Meckel syndrome (Baala_2007 and Khaddour_2007). Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as VUS (n=1), likely pathogenic (n=1) and pathogenic (n=1). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Joubert syndrome 6 Pathogenic:1
- -
TMEM67-related disorder Pathogenic:1
The TMEM67 c.651+2T>G variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant has been reported in individuals with Joubert syndrome and Meckel-Gruber syndrome (Baala et al. 2007. PubMed ID: 17160906; Khaddour et al. 2007. PubMed ID: 17397051). This variant is reported in 0.011% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Variants that disrupt the consensus splice donor site in TMEM67 are expected to be pathogenic. Given the evidence, we interpret this variant as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at